King Abdul-Aziz University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Riyadh Saudi Arabia (2005)

Organization Overview

First Clinical Trial
2007
NCT00426010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Assistant Professor, Department of Oral and Maxillofacial Prosthodontics, King Abdul-Aziz University, Jeddah, Saudi Arabia | Assistant Professor, Department of Pediatric Dentistry King Abdulaziz University | Assistant Professor, Department of Restorative Dentistry, King Abdul-Aziz University, Jeddah, Saudi Arabia | Center of Excellence for Osteoporosis Research and Faculty of Medicine, King Abdulaziz University | Center of Excellence for Osteoporosis Research, and Faculty of Medicine, King Abdulaziz University | Chair for Biomarkers of Chronic Diseases | Heba sabbagh | KAIMRC, King Saud bin Abdulaziz University for Health Sciences, Pharmaceutical Care Department, King Khalid Hospital, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia, Harvard T. H. Chan School of Public Health, Boston, MA, USA | King Abdelaziz University | King AbdulAziz City for Science and Technology | King Abdulaziz Medical City | King Abdul Aziz Medical City for National Guard | King Abdulaziz Medical City, National Guard / Riyadh-Saudi Arabia | King Abdulaziz Medical city , WR | King Abdulaziz National Guard Hospital, Riyadh | King Abdulaziz National Guard Hospital, Riyadh, Kingdom of Saudi Arabia | King Abdul Aziz Specialist Hospital | King Abdulaziz University | King Abdulaziz University, Faculty of Dentistry | King Abdulaziz University, jeddah, Saudi Arabia | King Abdullah Medical City | King Saud Bin Abdulaziz University for Health Sciences